Angioedema risk not greater among new users of ARNI compared to users of ACE Inhibitors, ARBs Medha Baranwal27 Jan 2023 5:15 AM GMTThe study supports starting with sacubitril/valsartan, not switching to it in heart failure patients. USA: An increased risk of angioedema was...
JB Pharma slashes price of critical Heart Failure medicine AZMARDA (Sacubitril-Valsartan) by nearly 50 percent Ruchika Sharma5 Dec 2022 9:07 AM GMT"This move by JB will not only help reduce the cost of treatment but will also help enhance the productive years of patients and their quality of...
Managing Heart Failure in India with Sacubitril Valsartan: Lessons from Clinical Trials Dr. Prem Aggarwal19 Sep 2022 6:05 AM GMTChronic Heart Failure (CHF) is a complex syndrome in which the heart cannot provide adequate cardiac output to meet the body's metabolic requirements...
Managing heart failure with sacubitril-valsartan: Why ARNIs stand out? dr. Abhimanyu Uppal30 July 2022 5:48 AM GMTHeart failure (HF) is a major economic and health burden worldwide, characterized by the presence of dyspnea or limited exertion due to impaired...
LIFE Trial: sacubitril/valsartan combination not effective to treat HF Dr. Nandita Mohan11 Feb 2022 1:31 PM GMTThe LIFE trial highlights that combination sacubitril/valsartan did not reduce N-terminal pro b-type natriuretic peptide (NT-proBNP) or clinical...
PARADISE MI Trial: sacubitril/valsartan effective for heart attack Dr. Nandita Mohan11 Feb 2022 1:03 PM GMTThe PARADISE -MI trial assesed the efficacy and safety of sacubitril/valsartan compared with ramipril in a contemporary acute myocardial...
Sacubitril-valsartan initiation in CHF may significantly decrease sleep apnea severity Josepha James14 Jun 2021 3:45 AM GMTSleep Apnoea (SA) is a highly prevalent co-morbidity in chronic heart failure patients associated with even worse outcomes. At least 50% of CHF...
